GlassScriptPhysician profile
Victor O Bacani
NPI 1932181351
$6,349.67
in general payments reported to CMS, 2019-2025
34 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,170 · 2020: $668 · 2021: $636 · 2022: $953 · 2023: $1,545 · 2024: $994 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,921.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,109.96 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $870.54 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $790.28 | 2019-2025 | Aveir, Amplatzer Amulet, Jot Dx |
| Astrazeneca Pharmaceuticals LP | $728.00 | 2020-2025 | Farxiga, Wainua, Breztri |
| Boston Scientific Corporation | $535.71 | 2019-2023 | S-Icd System Magnet, Bodyguardian |
| Amgen INC. | $437.27 | 2019-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $399.01 | 2019-2025 | |
| Pfizer INC. | $276.66 | 2019-2025 | |
| Novo Nordisk INC | $169.59 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Opko Pharmaceuticals, LLC | $125.00 | 2022 | |
| Atricure, INC. | $114.19 | 2020 | |
| Itamar Medical INC | $95.65 | 2023 | Watchpatone |
| Merck Sharp & Dohme LLC | $79.07 | 2022-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.65 | 2021-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $56.93 | 2020-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $50.01 | 2022-2023 | |
| Edwards Lifesciences Corporation | $47.88 | 2022-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $43.87 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.62 | 2022-2023 | Lifevest |
| Cvrx, INC. | $31.73 | 2023 | Barostim Neo System |
| Philips North America LLC | $30.51 | 2025 | Extended Holter |
| Bardy Diagnostics, INC. | $30.00 | 2020-2021 | |
| Amarin Pharma, INC. | $26.92 | 2020 | |
| Scpharmaceuticals INC. | $26.22 | 2025 | |
| Heartflow, INC. | $23.69 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $23.33 | 2024 | |
| Convatec INC. | $18.30 | 2024 | |
| Medtronic, INC. | $17.56 | 2023 | Micra |
| Regeneron Healthcare Solutions, INC. | $15.91 | 2023 | Evkeeza |
| Irhythm Technologies, INC. | $15.13 | 2022 | |
| Kestra Medical Technology Services, INC. | $14.23 | 2023 | Assure Wcd |
| Acarix USA INC. | $13.55 | 2024 | Cadscor System |
| Medtronic Vascular, INC. | $12.50 | 2019 | |
| Gilead Sciences, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Bacani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.